Terms: = Germ cell tumor AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
18 results:
1. p300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma.
Cheng C; He T; Chen K; Cai Y; Gu Y; Pan L; Duan P; Wu Y; Wu Z
Mol Cell Proteomics; 2023 Mar; 22(3):100504. PubMed ID: 36708875
[TBL] [Abstract] [Full Text] [Related]
2. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
[TBL] [Abstract] [Full Text] [Related]
3. CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis.
Yang H; Liu X; Zhu X; Li X; Jiang L; Zhong M; Zhang M; Chen T; Ma M; Liang X; Lv K
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34784299
[TBL] [Abstract] [Full Text] [Related]
4. Distinct genomic profiles of gestational choriocarcinoma, a unique cancer of pregnant tissues.
Jung SH; Choi YJ; Kim MS; Park HC; Han MR; Hur SY; Lee AW; Shin OR; Kim J; Lee SH; Hong D; Song SY; Chung YJ; Lee SH
Exp Mol Med; 2020 Dec; 52(12):2046-2054. PubMed ID: 33319857
[TBL] [Abstract] [Full Text] [Related]
5. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
[TBL] [Abstract] [Full Text] [Related]
6. Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.
Liu YS; Hsu JW; Lin HY; Lai SW; Huang BR; Tsai CF; Lu DY
Neuropharmacology; 2019 Jan; 144():143-154. PubMed ID: 30366000
[TBL] [Abstract] [Full Text] [Related]
7. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract] [Full Text] [Related]
8. The tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W
J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685
[TBL] [Abstract] [Full Text] [Related]
9. A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma.
Bhandaru M; Ardekani GS; Zhang G; Martinka M; McElwee KJ; Li G; Rotte A
BMC Cancer; 2014 Jun; 14():398. PubMed ID: 24893747
[TBL] [Abstract] [Full Text] [Related]
10. Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients.
Rotte A; Bhandaru M; Cheng Y; Sjoestroem C; Martinka M; Li G
PLoS One; 2013; 8(9):e75405. PubMed ID: 24098694
[TBL] [Abstract] [Full Text] [Related]
11. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract] [Full Text] [Related]
12. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract] [Full Text] [Related]
13. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract] [Full Text] [Related]
14. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.
Lu H; Li Y; Shu M; Tang J; Huang Y; Zhou Y; Liang Y; Yan G
FEBS J; 2009 Dec; 276(24):7291-304. PubMed ID: 19912340
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.
Ulasov IV; Tyler MA; Rivera AA; Nettlebeck DM; Douglas JT; Lesniak MS
J Med Virol; 2008 Sep; 80(9):1595-603. PubMed ID: 18649343
[TBL] [Abstract] [Full Text] [Related]
17. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
[TBL] [Abstract] [Full Text] [Related]
18. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q.
Tews B; Roerig P; Hartmann C; Hahn M; Felsberg J; Blaschke B; Sabel M; Kunitz A; Toedt G; Neben K; Benner A; von Deimling A; Reifenberger G; Lichter P
Oncogene; 2007 Jul; 26(34):5010-6. PubMed ID: 17311001
[TBL] [Abstract] [Full Text] [Related]
